168 related articles for article (PubMed ID: 37523119)
21. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
[TBL] [Abstract][Full Text] [Related]
22. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
[TBL] [Abstract][Full Text] [Related]
23. Identification of gastric cancer stem cells using the cell surface marker CD44.
Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
[TBL] [Abstract][Full Text] [Related]
24. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract][Full Text] [Related]
25. c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells.
Tomizawa F; Jang MK; Mashima T; Seimiya H
Biochem Biophys Res Commun; 2020 Jul; 527(4):1014-1020. PubMed ID: 32439168
[TBL] [Abstract][Full Text] [Related]
26. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
27. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
[TBL] [Abstract][Full Text] [Related]
28. Comparison of EpCAM
Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
[TBL] [Abstract][Full Text] [Related]
29. siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition.
Zou W; Zhang Y; Bai G; Zhuang J; Wei L; Wang Z; Sun M; Wang J
J Cell Mol Med; 2022 Apr; 26(7):1969-1978. PubMed ID: 35229451
[TBL] [Abstract][Full Text] [Related]
30. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
[TBL] [Abstract][Full Text] [Related]
32. Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
Kuo YC; Kou HW; Hsu CP; Lo CH; Hwang TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108495
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386
[TBL] [Abstract][Full Text] [Related]
36. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
37. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
38. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
[TBL] [Abstract][Full Text] [Related]
39. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
[TBL] [Abstract][Full Text] [Related]
40. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
